ALFA FinderNSE filing, NSE: MEDISTEP. Summary written from the filing by ALFA Finder's alert engine.
Medistep Healthcare Ltd: key numbers
- Share price
- ₹18.90
- Market cap
- ₹26.86 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹5.98 Cr
- P/E (TTM)
- 4.5×Sector 43.8×
- Promoter holding
- 68.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medistep Healthcare Ltd
All →Medistep Healthcare H1 FY27 Results: Net Profit ₹3.1 Cr, Up 3.3% YoY
Medistep Healthcare Ltd reported revenue from operations of ₹37.4 Cr (+6.6% YoY) and net profit of ₹3.1 Cr (+3.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.1 Cr · +3.3% YoY
Medistep Healthcare Other Announcement
Medistep Healthcare Limited has submitted the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.
Medistep Healthcare Other Announcement
Medistep Healthcare Limited has appointed M/s. Kapil Kumar Agarwal & Associates as Internal Auditor and M/s. Vaibhav Sharma & Associates as Secretarial Auditor.
Medistep Healthcare Board Meeting Outcome
Medistep Healthcare Limited announced the outcome of its board meeting held on August 24, 2026. Key decisions include notice for the AGM and appointment of auditors.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited has issued a notice for its 3rd Annual General Meeting (AGM) to be held on September 17, 2026. The filing includes the company's annual report.
Other board meeting date announcements
All →RRP Defense Board Meeting Date
RRP Defense Ltd scheduled a board meeting for 14 Nov 2026 to consider Q2 and half-year financial results. No decisions have been taken yet; agenda items are proposed only.
Sukhjit Starch & Chemicals Board Meeting Date
Sukhjit Starch & Chemicals will consider a buyback proposal at its board meeting on 20 November 2026. The trading window stays closed until the meeting concludes.
Dhruva Capital Services Board Meeting Date
Dhruva Capital Services postponed its Q2/H1 FY27 results Board Meeting to November 13, 2026. The trading window stays closed until November 15, 2026.
Mitshi India Board Meeting Date
Mitshi India rescheduled its board meeting from 13 Nov to 14 Nov 2026 due to non-availability of directors. The meeting's agenda includes Q2/H1 2026 financial results approval.
Magnus Steel and Infra Board Meeting Date
Magnus Steel and Infra has scheduled its board for 14 Nov 2026 to approve standalone results for the quarter and half year ended 30 Sep 2026. The trading window is closed from 1 Oct 2026.
Ansal Properties & Infrastructure Board Meeting Date
Ansal Properties & Infrastructure intimated that its Board will meet on 18 Nov 2026 to approve Q1 FY27 standalone results. The meeting is scheduled and has not yet been held.